[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356788-105":3,"doc-detail-356788-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comprehensive-profiling-of-rpp40-across-human-cancers-reveals-its-essential-role-and-multidimensional-clinical-correlates","Comprehensive profiling of RPP40 across human cancers reveals its essential role and multidimensional clinical correlates","","Background Ribonuclease P/MRP subunit p40 (RPP40) is a core component of the RNase P/MRP ribonucleoprotein complex, driving RNA processing. Its systematic features, clinical relevance, and underlying functions across pan-cancer landscapes remain insufficiently defined. Methods Pan-cancer expression, CRISPR screening, single-cell RNA sequencing, immunohistochemistry, proteomics, and multi-level survival analyses were integrated, alongside correlations with tumor stage, response, immune subtype, and demographics. Results RPP40 was upregulated in most cancers, linked to advanced stage and poor survival. Conclusion RPP40 emerges as an actionable pan-cancer prognostic biomarker and therapeutic target, supported by multi-level clinical–molecular integrative evidence.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comprehensive-profiling-of-rpp40-across-human-cancers-reveals-its-essential-role-and-multidimensional-clinical-correlates/356788/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comprehensive-profiling-of-rpp40-across-human-cancers-reveals-its-essential-role-and-multidimensional-clinical-correlates/356788.png","ImageObject",300,407,{"name":42,"@type":43},"Rizky","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does RPP40 play in RNA processing and cancer biology?","Question",{"text":63,"@type":64},"RPP40 is a core subunit of the RNase P/MRP complex that regulates RNA processing. The study links its dysregulation to tumor proliferation, survival, and cell-cycle programs across cancers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was RPP40 analyzed across multiple cancer types?",{"text":68,"@type":64},"The study combined multi-omics pan-cancer expression profiling with CRISPR screening, single-cell RNA sequencing, immunohistochemistry, proteomics, and multi-level survival analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinical outcomes and features are associated with high RPP40 expression?",{"text":72,"@type":64},"Higher RPP40 expression correlates with advanced tumor stage and poor prognosis, and it shows associations with multiple pathological and clinical indicators including major tumor subtypes and smoking history.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356788,1790557515,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8",8,"Man and He Discover Oncology (2026) 17:734 [https://doi.org/10.1007/s12672-026-04919-z](https://doi.org/10.1007/s12672-026-04919-z)  \nDiscover Oncology  \nANALYSIS Open Access  \nComprehensive profiling of RPP40 across human cancers reveals its essential role and multidimensional clinical correlates  \nYu-Nan Man 1 and Mao-Lin He 1*  \n*Correspondence:  \nMao-Lin He[hemaolin@stu.gxmu.edu.cn](hemaolin@stu.gxmu.edu.cn)[ ](hemaolin@stu.gxmu.edu.cn)1The First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road,  \nNanning 530021, Guangxi Zhuang Autonomous Region, China  \nAbstract  \nBackground Ribonuclease P/MRP subunit p40 (RPP40) is a core component of the RNase P/MRP ribonucleoprotein complex, playing a central role in RNA processing. However, its systematic characteristics, clinical significance, and functional mechanisms at the pan-cancer level remain unclear.  \nMethods We systematically characterized the pan-cancer expression profile and prognostic value of RPP40 using multi-omics approaches, including pan  \ncancer expression profiling, CRISPR screening, single-cell RNA sequencing, immunohistochemistry, proteomics, and multi-level survival analyses. We further examined correlations between RPP40 expression and diverse clinical indicators, including tumor stage, treatment response, immune subtype, and demographic characteristics.  \nResults RPP40 expression was significantly upregulated in most cancers and their subtypes, and it was identified as a broadly essential gene for cancer cell survival. High RPP40 expression was significantly associated with advanced tumor stage and poor prognosis, serving as an independent risk factor for overall survival and progressionfree survival across multiple independent cohorts. Our multidimensional analytical framework further revealed significant associations between RPP40 expression and various features, including pathological stage, major tumor subtypes, and smoking history. Functionally, RPP40 likely promotes tumor proliferation by activating cell cycle pathways, and its expression displays strong cell cycle dependency.  \nConclusion This study systematically elucidates the oncogenic role of RPP40 across cancers, establishing it as a novel and translationally promising pan-cancer prognostic biomarker and a potential therapeutic target. The “multi-level clinical–molecular integrative analysis” framework developed herein provides foundational evidence and data support for subsequent precision therapeutic strategies targeting RPP40 . Keywords RPP40, RNA processing, Prognostic biomarker, Cell cycle  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4.0/.  \n1 Introduction  \nTumors exhibit substantial heterogeneity, with pronounced variation in molecular drivers and clinical outcomes not only across cancer types but also among subtypes within the same malignancy [1–4]. Although single-cancer studies have advanced our understanding, pan-cancer analyses remain relatively limited, hin","cbCaisQyga3MT6uk","https://ap.wps.com/l/cbCaisQyga3MT6uk","pdf",4741424,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What role does RPP40 play in RNA processing and cancer biology?\",\"answer\":\"RPP40 is a core subunit of the RNase P/MRP complex that regulates RNA processing. The study links its dysregulation to tumor proliferation, survival, and cell-cycle programs across cancers.\"},{\"question\":\"How was RPP40 analyzed across multiple cancer types?\",\"answer\":\"The study combined multi-omics pan-cancer expression profiling with CRISPR screening, single-cell RNA sequencing, immunohistochemistry, proteomics, and multi-level survival analyses.\"},{\"question\":\"What clinical outcomes and features are associated with high RPP40 expression?\",\"answer\":\"Higher RPP40 expression correlates with advanced tumor stage and poor prognosis, and it shows associations with multiple pathological and clinical indicators including major tumor subtypes and smoking history.\"}]","Comprehensive profiling of RPP40 across human cancers reveals its essential role and multidimensional clinical correlates | PDF",1790127301,43,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3586e7b6893901f57f81e74d7fc8e4c.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5826f79f17ffe36244622fd160d43886.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79d831aa455a1a3e29e4be5687938e03.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc1bbf4de93a9f842903ffb50eada776.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,134,139,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},"Comic",60,"comic",{"id":135,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},6,"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":55,"slug":162},19,"General","general"]